KP1019, A New Redox-Active Anticancer Agent - Preclinical Development and Results of a Clinical Phase I Study in Tumor Patients

Hartinger, Christian G.; Jakupec, Michael A.; Zorbas-Seifried, Stefanie; Grössl, Michael; Egger, Alexander; Berger, Walter; Zorbas, Haralabos; Dyson, Paul J.; Keppler, Bernhard K. (2008). KP1019, A New Redox-Active Anticancer Agent - Preclinical Development and Results of a Clinical Phase I Study in Tumor Patients. Chemistry & Biodiversity, 5(10), pp. 2140-2155. Verlag Helvetica Chimica Acta 10.1002/cbdv.200890195

[img] Text
Hartinger_et_al-2008-Chemistry_&_Biodiversity.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (355kB) | Request a copy

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Nephrology and Hypertension

UniBE Contributor:

Grössl, Michael

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1612-1872

Publisher:

Verlag Helvetica Chimica Acta

Language:

English

Submitter:

Michael Grössl

Date Deposited:

04 Oct 2019 15:50

Last Modified:

24 Oct 2019 09:14

Publisher DOI:

10.1002/cbdv.200890195

PubMed ID:

18972504

BORIS DOI:

10.7892/boris.112154

URI:

https://boris.unibe.ch/id/eprint/112154

Actions (login required)

Edit item Edit item
Provide Feedback